V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16651997 | 330017641 | ECL02 | 48 | X724 | 1 | 2014-08-14 | CYTARABINE | 330003453 | 330011601 | 330006717 |
| 16651998 | 330017641 | EEI00 | 70 | X721 | 1 | 2014-08-14 | CISPLATIN | 330003453 | 330011601 | 330006717 |
| 16651999 | 330017641 | EGT | 100 | X722 | 1 | 2014-08-14 | CISPLATIN | 330003453 | 330011601 | 330006717 |
| 16652000 | 330017641 | EKA | 8 | X724 | 2 | 2014-08-14 | STEROID | 330003453 | 330011601 | 330006717 |
| 16652001 | 330017642 | E0N07 | 140 | X724 | 2 | 2016-05-10 | CISPLATIN | 330003453 | 330011601 | 330006718 |
| 16652002 | 330017642 | EW100 | 100 | X722 | 1 | 2016-05-10 | DEXAMETHASONE | 330003453 | 330011601 | 330006718 |
| 16652003 | 330017642 | EPH | 2 | null | 1 | 2016-05-10 | VINCRISTINE | 330003453 | 330011601 | 330006718 |
| 16652004 | 330017642 | EEI00 | 52 | X721 | 1 | 2016-05-11 | DOXORUBICIN | 330003453 | 330011601 | 330006718 |
| 16652005 | 330017642 | EW100 | 112 | X721 | 1 | 2016-05-11 | CISPLATIN | 330003453 | 330011601 | 330006718 |
| 16652006 | 330017642 | EW100 | 4970 | X724 | 1 | 2016-05-11 | FLUOROURACIL | 330003453 | 330011601 | 330006718 |
| 16652007 | 330017643 | EPS | 4 | x702 | 2 | 2016-02-25 | STEROID | 330003471 | 330003475 | 330006720 |
| 16652008 | 330017643 | EKJ | 100 | X722 | 1 | 2016-02-27 | CETUXIMAB | 330003471 | 330003475 | 330006720 |
| 16652009 | 330017643 | EPH | 20 | X724 | 2 | 2016-02-27 | NOT CHEMO | 330003471 | 330003475 | 330006720 |
| 16652010 | 330017643 | EEI00 | 2800 | X721 | 1 | 2016-03-05 | ETOPOSIDE | 330003471 | 330003475 | 330006720 |
| 16652011 | 330017645 | EKA | 240 | null | 1 | 2017-03-19 | ETOPOSIDE | 330003481 | 330003478 | 330006723 |
| 16652012 | 330017646 | EKJ | 240 | X724 | 2 | 2014-11-19 | ETOPOSIDE | 330003485 | 330003480 | 330006725 |
| 16652013 | 330017646 | EEX02 | 478 | X722 | 1 | 2014-11-19 | CETUXIMAB | 330003485 | 330003480 | 330006725 |
| 16652014 | 330017646 | EKU06 | 35 | null | 2 | 2014-11-20 | NOT CHEMO | 330003485 | 330003480 | 330006725 |
| 16652015 | 330017646 | EEI00 | 20 | null | 1 | 2014-11-27 | METHOTREXATE | 330003485 | 330003480 | 330006725 |
| 16652016 | 330017646 | EW100 | 10 | X722 | 1 | 2014-11-27 | NOT CHEMO | 330003485 | 330003480 | 330006725 |
| 16652017 | 330017647 | ELW | 210 | X724 | 1 | 2018-03-29 | ETOPOSIDE | 330003509 | 330003486 | 330006728 |
| 16652018 | 330017647 | EEI00 | 150 | X729 | 1 | 2018-03-29 | NOT CHEMO | 330003509 | 330003486 | 330006728 |
| 16652019 | 330017648 | EOI | 95 | null | 2 | 2014-09-29 | CISPLATIN | 330003517 | 330003487 | 330006729 |
| 16652020 | 330017648 | EUH | 500 | X722 | 1 | 2014-09-29 | CETUXIMAB | 330003517 | 330003487 | 330006729 |
| 16652021 | 330017648 | EE813 | 1.3 | X724 | 1 | 2014-09-29 | VINCRISTINE | 330003517 | 330003487 | 330006729 |
| 16652022 | 330017648 | EK1EN | 0 | X721 | 1 | 2014-09-29 | DOXORUBICIN | 330003517 | 330003487 | 330006729 |
| 16652023 | 330017648 | ETG01 | 0 | null | 1 | 2014-09-29 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16652024 | 330017648 | EW100 | null | null | 2 | 2014-09-30 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16652025 | 330017648 | EJN | 10 | null | 1 | 2014-10-01 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16652026 | 330017648 | EX950 | 10 | X724 | 2 | 2014-10-01 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16652027 | 330017648 | EWM01 | 100 | X724 | 1 | 2014-10-01 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16652028 | 330017649 | EK1PP | 110 | X721 | 1 | 2015-01-07 | ETOPOSIDE | 330003517 | 330003487 | 330006730 |
| 16652029 | 330017649 | EW100 | 400 | X722 | 1 | 2015-01-07 | CETUXIMAB | 330003517 | 330003487 | 330006730 |
| 16652030 | 330017649 | EWR01 | 3 | X724 | 2 | 2015-01-07 | STEROID | 330003517 | 330003487 | 330006730 |
| 16652031 | 330017650 | eke10 | 100 | X721 | 1 | 2018-01-15 | NOT CHEMO | 330003521 | 330003490 | 330006731 |
| 16652032 | 330017650 | EUDJC | 8 | null | 1 | 2018-01-22 | CETUXIMAB | 330003521 | 330003490 | 330006731 |
| 16652033 | 330017650 | EC4 | 19 | null | 1 | 2018-01-22 | DOXORUBICIN | 330003521 | 330003490 | 330006731 |
| 16652035 | 330017652 | EUDJC | 8 | X721 | 1 | 2014-02-12 | STEROID | 330003528 | 330003493 | 330006733 |
| 16652036 | 330017653 | EGU02 | 110 | X721 | 2 | 2018-03-01 | ETOPOSIDE | 330003531 | 330012339 | 330006735 |
| 16652037 | 330017653 | EW100 | 450 | X722 | 1 | 2018-03-01 | NOT CHEMO | 330003531 | 330012339 | 330006735 |
| 16652038 | 330017653 | EN723 | 650 | X724 | 2 | 2018-03-01 | MERCAPTOPURINE | 330003531 | 330012339 | 330006735 |
| 16652039 | 330017653 | EEI00 | 38 | X721 | 1 | 2018-03-01 | CISPLATIN | 330003531 | 330012339 | 330006735 |
| 16652040 | 330017653 | EGT | 80 | null | 1 | 2018-03-01 | DOXORUBICIN | 330003531 | 330012339 | 330006735 |
| 16652041 | 330017653 | EJU04 | 1650 | X724 | null | 2018-03-01 | FLUOROURACIL | 330003531 | 330012339 | 330006735 |
| 16652042 | 330017653 | EN901 | 485 | X724 | 2 | 2018-03-09 | CETUXIMAB | 330003531 | 330012339 | 330006735 |
| 16652043 | 330017655 | EOI | 124 | null | 1 | 2013-09-15 | CISPLATIN | 330003558 | 330003497 | 330006740 |
| 16652044 | 330017656 | EOI | 200 | null | 1 | 2015-05-24 | ETOPOSIDE | 330003558 | 330003497 | 330006741 |
| 16652045 | 330017656 | EW100 | 300 | X722 | 1 | 2015-05-25 | CETUXIMAB | 330003558 | 330003497 | 330006741 |
| 16652046 | 330017656 | EC4 | 27.5 | X724 | 2 | 2015-06-22 | STEROID | 330003558 | 330003497 | 330006741 |
| 16652047 | 330017656 | EEI00 | 47 | null | 1 | 2015-06-22 | DOXORUBICIN | 330003558 | 330003497 | 330006741 |